Brain-Derived Neurotrophic Factor Enhances the Excitability of Small-Diameter Trigeminal Ganglion Neurons Projecting to the Trigeminal Nucleus Interpolaris/Caudalis Transition Zone following Masseter Muscle Inflammation
Open Access
- 1 January 2013
- journal article
- research article
- Published by SAGE Publications in Molecular Pain
- Vol. 9, 49
Abstract
Background: The trigeminal subnuclei interpolaris/caudalis transition zones (Vi/Vc) play an important role in orofacial deep pain, however, the role of primary afferent projections to the Vi/Vc remains to be determined. This study investigated the functional significance of hyperalgesia to the brain-derived neurotrophic factor (BDNF)-tyrosine kinase B (trkB) signaling system in trigeminal ganglion (TRG) neurons projecting to the Vi/Vc transition zone following masseter muscle (MM) inflammation. Results: The escape threshold from mechanical stimulation applied to skin above the inflamed MM was significantly lower than in naïve rats. Fluorogold (FG) labeling was used to identify the TRG neurons innervating the MM, while microbeads (MB) were used to label neurons projecting to the Vi/Vc region. FG/MB-labeled TRG neurons were immunoreactive (IR) for BDNF and trkB. The mean number of BDNF/trkB-IR small/medium-diameter TRG neurons was significantly higher in inflamed rats than in naïve rats. In whole-cell current-clamp experiments, the majority of dissociated small-diameter TRG neurons showed a depolarization response to BDNF that was associated with spike discharge, and the concentration of BDNF that evoked a depolarizing response was significantly lower in the inflamed rats. In addition, the relative number of BDNF-induced spikes during current injection was significantly higher in inflamed rats. The BDNF-induced changes in TRG neuron excitability was abolished by tyrosine kinase inhibitor, K252a. Conclusion: The present study provided evidence that BDNF enhances the excitability of the small-diameter TRG neurons projecting onto the Vi/Vc following MM inflammation. These findings suggest that ganglionic BDNF-trkB signaling is a therapeutic target for the treatment of trigeminal inflammatory hyperalgesia.Keywords
This publication has 61 references indexed in Scilit:
- Extrasynaptic exocytosis and its mechanisms: a source of molecules mediating volume transmission in the nervous systemFrontiers in Physiology, 2012
- Up-regulation of dorsal root ganglia BDNF and trkB receptor in inflammatory pain: an in vivo and in vitrostudyJournal of Neuroinflammation, 2011
- Tumor necrosis factor-α increases brain-derived neurotrophic factor expression in trigeminal ganglion neurons in an activity-dependent mannerNeuroscience, 2011
- The Role Of Trigeminal Interpolaris-Caudalis Transition Zone In Persistent Orofacial Pain2011
- Reduction in voltage‐gated K+channel activity in primary sensory neurons in painful diabetic neuropathy: role of brain‐derived neurotrophic factorJournal of Neurochemistry, 2010
- Tooth pulp inflammation increases brain-derived neurotrophic factor expression in rodent trigeminal ganglion neuronsNeuroscience, 2010
- Brain‐derived neurotrophic factor enhances the excitability of rat sensory neurons through activation of the p75 neurotrophin receptor and the sphingomyelin pathwayThe Journal of Physiology, 2008
- Calcitonin gene‐related peptide enhances release of native brain‐derived neurotrophic factor from trigeminal ganglion neuronsJournal of Neurochemistry, 2006
- Correlation between the Appearance of Neuropeptides in the Rat Trigeminal Ganglion and Reinnervation of the Healing Root Socket after Tooth ExtractionACTA HISTOCHEMICA ET CYTOCHEMICA, 2006
- Ethical guidelines for investigations of experimental pain in conscious animalsPain, 1983